PROAbbott Laboratories
stock101.82
+2.22 (+2.23%)
Price as of 13 Oct, 16:08 · Rate limit reached. Please try again in a minute.
Good Money Guide Pro Score
Neutral
Mixed investment profile
Technical Analysis
Short-Term Outlook
Bullish
3 bull · 0 bear · 2 neutral
Medium-Term Outlook
Neutral
2 bull · 2 bear · 0 neutral
Price below 50-day MA
Price below 200-day MA
Price above 12-day EMA
Price above 26-day EMA
Neutral momentum zone
MACD above signal line
%K above %D
Price near middle band
Volatility measure — informational only
Volume Indicators
On Balance Volume (OBV)
Volume Accumulation Distribution (VAD)
Market Statistics
Day Change
+2.22
Market Cap
175365751000
Exchange
NYSE
Sector
Health Care
Fundamentals
Rate limit reached. Please try again in a minute.
Analyst Forecast
Rate limit reached. Please try again in a minute.
Fundamental Analysis
Unable to load fundamental data
Learn about Abbott Laboratories
What is Abbott Laboratories?
Abbott Laboratories is a global leader in the healthcare industry, specializing in the development of medical devices, diagnostic tests, nutrition products, and branded generic medicines. They operate across a wide range of health sectors, helping patients manage chronic conditions and providing essential tools for clinical laboratories and hospitals worldwide.
Is Abbott Laboratories a good investment?
Abbott is often favored by long-term investors for its consistent history of dividend payments and diversified business model, which helps provide stability during market volatility. However, potential investors should consider the risks of heavy regulatory oversight and intense competition in the medical technology field. Please note that this information is for educational purposes only and does not constitute financial or investment advice.
How do you invest in Abbott Laboratories?
To gain exposure to Abbott Laboratories, you can purchase individual shares through a brokerage account by searching for its ticker symbol, ABT. Alternatively, you can invest in the company indirectly by purchasing shares of broad-market index funds or healthcare-focused exchange-traded funds (ETFs) that hold Abbott within their portfolios.
Educational content generated by AI — not financial advice.
Time & Sales
No trades yet.
News & Sentiment
Rate limit reached. Please try again in a minute.
Community Discussion
No posts yet for ABT — be the first to start the discussion.
Point & Figure Analysis
OHLC
Signals
as of 07 Oct 2026Targets
No active targets — trend is consolidating.
Famous Investors Holding ABT
Ken Griffin
8.08M sh · 0.1% of portfolio
$732.79M
NEW
Ken Griffin
2.58M sh · 0.0% of portfolio
$234.27M
NEW
Ken Griffin
887.9K sh · 0.0% of portfolio
$80.57M
NEW
Jim Simons
686.4K sh · 0.1% of portfolio
$62.28M
NEW
Ken Griffin
521.5K sh · 0.0% of portfolio
$47.32M
NEW
Ken Fisher
505.4K sh · 0.0% of portfolio
$45.86M
NEW
Ray Dalio
59.8K sh · 0.0% of portfolio
$5.42M
NEW
Mario Gabelli
21.7K sh · 0.0% of portfolio
$1.97M
NEW
Source: SEC Form 13F, reporting period 30 Jun 2026. 45-day lag applies.